We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+6.33%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$1.33B
AUM Growth
+$253M
(+24%)
Cap. Flow
+$204M
Cap. Flow
% of AUM
15.35%
Top 10 Holdings %
Top 10 Hldgs %
6.81%
Holding
1,856
New
682
Increased
391
Reduced
238
Closed
544
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Motors
GM
|
+$11.1M |
| 2 |
RTX Corp
RTX
|
+$7.48M |
| 3 |
Whirlpool
WHR
|
+$7.35M |
| 4 |
Illinois Tool Works
ITW
|
+$7.03M |
| 5 |
Adobe
ADBE
|
+$6.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$12.3M |
| 2 |
NVIDIA
NVDA
|
+$10.8M |
| 3 |
Microsoft
MSFT
|
+$10.7M |
| 4 |
Motorola Solutions
MSI
|
+$7.95M |
| 5 |
Apple
AAPL
|
+$7.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.39% |
| 2 | Consumer Discretionary | 14.49% |
| 3 | Industrials | 14.29% |
| 4 | Technology | 12.79% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Vir Biotechnology
VIR
$1.48B
| $186K | 0.01% |
+18,320
| New | +$187K |
|
|
ACCD
1177
DELISTED
Accolade Inc
ACCD
| $185K | 0.01% |
17,699
+3,110
| +21% | +$35.4K |
|
1178
MBIA
MBI
$282M
| $185K | 0.01% |
+27,431
| New | +$174K |
|
1179
AXT Inc
AXTI
$3.13B
| $185K | 0.01% |
+40,235
| New | +$137K |
|
1180
Carlyle Secured Lending
CGBD
$710M
| $185K | 0.01% |
+11,340
| New | +$178K |
|
|
APLT
1181
DELISTED
Applied Therapeutics
APLT
| $184K | 0.01% |
27,017
+15,969
| +145% | +$71.7K |
|
|
ZIMV
1182
DELISTED
ZimVie
ZIMV
| $183K | 0.01% |
+11,127
| New | +$198K |
|
1183
Sally Beauty Holdings
SBH
$1.43B
| $183K | 0.01% |
+14,739
| New | +$185K |
|
|
GLDD
1184
DELISTED
Great Lakes Dredge & Dock
GLDD
| $182K | 0.01% |
+20,857
| New | +$172K |
|
1185
Pediatrix Medical
MD
$2.15B
| $180K | 0.01% |
17,934
-154
| -0.9% | -$1.43K |
|
1186
Patria Investments
PAX
$1.76B
| $177K | 0.01% |
+11,894
| New | +$174K |
|
|
TBI
1187
Trueblue
TBI
$237M
| $176K | 0.01% |
+14,086
| New | +$182K |
|
1188
Cosan
CSAN
$3.05B
| $175K | 0.01% |
+13,536
| New | +$194K |
|
1189
Tiptree Inc
TIPT
$678M
| $173K | 0.01% |
+10,040
| New | +$180K |
|
|
PDM
1190
Piedmont Realty Trust
PDM
$1.22B
| $172K | 0.01% |
24,421
-48,984
| -67% | -$328K |
|
1191
Amneal Pharmaceuticals
AMRX
$5.78B
| $170K | 0.01% |
+28,123
| New | +$159K |
|
1192
Global Net Lease
GNL
$1.87B
| $168K | 0.01% |
+21,667
| New | +$178K |
|
1193
Nexa Resources
NEXA
$1.71B
| $168K | 0.01% |
+23,497
| New | +$164K |
|
|
PLYA
1194
DELISTED
Playa Hotels & Resorts
PLYA
| $168K | 0.01% |
17,318
-20,366
| -54% | -$180K |
|
1195
Kearny Financial
KRNY
$595M
| $166K | 0.01% |
+25,778
| New | +$180K |
|
1196
Stereotaxis
STXS
$130M
| $166K | 0.01% |
63,524
+30,987
| +95% | +$73.6K |
|
1197
Backblaze
BLZE
$739M
| $165K | 0.01% |
16,124
+4,864
| +43% | +$45K |
|
1198
N-able
NABL
$823M
| $164K | 0.01% |
12,547
-4,815
| -28% | -$63.7K |
|
1199
Xperi
XPER
$367M
| $163K | 0.01% |
+13,548
| New | +$149K |
|
1200
Cardiff Oncology
CRDF
$65M
| $157K | 0.01% |
+29,464
| New | +$78.3K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q1 2024 Portfolio in Review
As of Q1 2024, Y-Intercept (HK) held 1,856 positions worth $1.33B, up 24% from $1.07B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Y-Intercept (HK) deployed $204M of net new capital in Q1 2024, opening 682 new positions and adding to 391 existing holdings. Its largest new stake was General Motors: 287,173 shares worth $13M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Merck, an estimated $12.3M trimmed.
- Y-Intercept (HK)'s largest Q1 2024 buy was General Motors: 287,173 shares worth $13M.
- Y-Intercept (HK) added most to Illinois Tool Works in Q1 2024, an estimated $7.03M increase.
- Y-Intercept (HK)'s biggest Q1 2024 reduction was Merck, cutting an estimated $12.3M.
- Y-Intercept (HK) fully exited NVIDIA in Q1 2024, selling an estimated $10.8M.
- Y-Intercept (HK)'s ten largest holdings make up 6.8% of its $1.33B portfolio in Q1 2024.
- Y-Intercept (HK) opened 682 new positions and closed 544 in Q1 2024.
- Y-Intercept (HK)'s portfolio value rose 24% quarter-over-quarter to $1.33B.
Based on Y-Intercept (HK)'s 13F filing for Q1 2024, filed 10 May 2024.